Early-stage Prostate Cancer Rates Continued to Decline After Task Force Recommendations

Early-stage Prostate Cancer Rates Continued to Decline After Task Force Recommendations
The rates of PSA screening and early-stage prostate cancer incidence declined through 2013 following a U.S. Preventive Services Task Force (USPSTF) recommendation against routine PSA (prostate specific antigen) screening in primary care. The study, “Prostate Cancer Incidence Rates 2 Years After the US Preventive Services Task Force Recommendations Against Screening,“ was published in Jama Oncology. In 2011,

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.
Alexandra holds a BSc in psychology with continued studies in neuroscience and pharmacology. She also holds an interdisciplinary Med. Licentiate, merging the fields of neuropharmacology, psychiatry and immunology from the Karolinska Institute, Stockholm, Sweden. Her previous research focused on interaction between the immune- and neurotransmitter systems regarding psychotic disorders.

Leave a Comment

Your email address will not be published. Required fields are marked *